Musser, John H. published the artcilePhenylephrine derivatives as leukotriene D4 antagonists, Recommanded Product: 2-(Chloromethyl)-1-methyl-1H-benzo[d]imidazole, the publication is Journal of Medicinal Chemistry (1987), 30(11), 2087-93, database is CAplus and MEDLINE.
Two series of phenylephrine derivatives, e.g., I [R = H, Me; R1 = CONEt2, COEt, COPh, etc.; Z = (R)-CHOH, (±)-CHOH] and II (R2 = 1-methyl-2-oxopyrrolidin-4-yl) (III) were prepared from phenylephrines. Thus, condensing (R)-3-HOC6H4CH(OH)CH2NHMe.HCl with ClCONEt2 gave (R)-3-HOC6H4CH(OH)CH2NMeCONEt2, which was alkylated with 2-(chloromethyl)quinoline to give I [R = Me, R1 = CONEt2, Z = (R)-CH(OH)] (IV). The most potent compound of the urea series, IV, was active orally as an inhibitor of leukotriene D4 (LTD4)- and ovalbumin-induced bronchospasm in the guinea pig, with ED50 56 mg/kg vs. LTD4 and 55 mg/kg vs. ovalbumin. When tested as an antagonist of LTD4-induced contraction of isolated guinea pig tracheal strips, IV was a competitive inhibitor. In the 2nd series, III had oral ED50 36 mg/kg vs. LTD4 and 95 mg/kg vs. ovalbumin. III selectively antagonized contractile responses of guinea pig trachea evoked by LTD4. IV dilated the cat coronary artery and blocked the coronary constrictor effect of LTD4, and also preserved myocardial integrity in rats 48 h after coronary-artery ligation. When tested in the rat alc.-induced gastric lesion model, III and IV manifested a dose-dependent mucosal protection against EtOH.
Journal of Medicinal Chemistry published new progress about 4760-35-4. 4760-35-4 belongs to imidazoles-derivatives, auxiliary class Chloride,Benzimidazole, name is 2-(Chloromethyl)-1-methyl-1H-benzo[d]imidazole, and the molecular formula is C9H9ClN2, Recommanded Product: 2-(Chloromethyl)-1-methyl-1H-benzo[d]imidazole.
Referemce:
https://en.wikipedia.org/wiki/Imidazole,
Imidazole | C3H4N2 – PubChem